Complexo Hospitalario Universitario de Santiago
Centro de atención
Hospital de Manises
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital de Manises (17)
2023
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
-
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, Vol. 55, Núm. 1, pp. 46-52
2022
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
2020
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
2019
-
Multicentric study on total pancreatectomies
Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384
2018
-
Addition of granulocyte/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A Randomized multicentre clinical trial
Journal of Crohn's and Colitis, Vol. 12, Núm. 6, pp. 687-694
2017
-
Characterization of Surgical Procedures in the Spanish Mohs Surgery Registry (REGESMOHS) for 2013-2015
Actas Dermo-Sifiliograficas, Vol. 108, Núm. 9, pp. 836-843
-
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Seizure, Vol. 48, pp. 53-56
-
Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131
2016
-
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab
Biochemical Pharmacology, Vol. 122, pp. 33-41
-
Tuberculosis in anti-tumour necrosis factortreated inflammatory bowel disease patients after the implementation of preventive measures: Compliance with recommendations and safety of retreatment
Journal of Crohn's and Colitis, Vol. 10, Núm. 10
2015
-
Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data from the Spanish Registry of Mohs Surgery (REGESMOHS)
Actas Dermo-Sifiliograficas, Vol. 106, Núm. 7, pp. 562-568
2014
-
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study
Epilepsy Research, Vol. 108, Núm. 7, pp. 1243-1252
2012
-
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study
Inflammatory Bowel Diseases, Vol. 18, Núm. 5, pp. 812-817
-
Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning
Bone Marrow Transplantation, Vol. 47, Núm. 10, pp. 1343-1349